Loading...
Please wait, while we are loading the content...
Similar Documents
Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum]
| Content Provider | Scilit |
|---|---|
| Author | Cheng, Shih-Lung Ho, Ming-Lin Lai, Yun-Fa Wang, Hao-Chien Hsu, Jeng-Yuan Liu, Shih-Feng Huang, Ming-Shyang Lee, Cheng-Hung Lin, Ching-Hsiung Hang, Liang-Wen Liu, Yu-Chih Yang, Kuang-Yao Wang, Jia-Horng |
| Copyright Year | 2021 |
| Related Links | https://www.dovepress.com/getfile.php?fileID=66529 |
| Ending Page | 516 |
| Page Count | 2 |
| Starting Page | 515 |
| e-ISSN | 11778881 |
| DOI | 10.2147/dddt.s300704 |
| Journal | Drug design, development and therapy |
| Volume Number | 15 |
| Language | English |
| Publisher | Informa UK Limited |
| Publisher Date | 2021-02-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: Drug Design, Development and Therapy Allergy Respiratory System Optimally Budesonide/formoterol Fluticasone Propionate/salmeterol Maintenance Or Fluticasone Reliever and Maintenance Anti Inflammatory Reliever |
| Content Type | Text |
| Resource Type | Article |